With $1.9 Bil. Bid For Chattem, Sanofi Knocks On Door To U.S. OTC Market

With its $1.9 billion bid for personal-care and over-the-counter drug manufacturer Chattem, French pharmaceutical giant Sanofi-Aventis stands to gain a toehold in the sizeable U.S. consumer health sector and beef up its presence in emerging markets